Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

BL Cohen, DB Sachar - Bmj, 2017 - bmj.com
… colitis and Crohn’s disease, these inflammatory bowel diseases have grown to be … diseases
in the developed world. Although the causes and treatment of inflammatory bowel disease (…

Tumour necrosis factor and Crohn's disease.

SJ Van Deventer - Gut, 1997 - ncbi.nlm.nih.gov
… Tumour necrosis factor and Crohn's disease The production of several pro-inflammatory
cytokines is increased in inflammatory bowel diseases (IBD). Experimental models of IBD have …

Tumour necrosis factor and inflammatory bowel disease

AM Armstrong, KR Gardiner, SJ Kirk… - British journal of …, 1997 - Wiley Online Library
… Faecal and systemic tumour necrosis factor in experimental inflammatory bowel disease. …
Serum concentrations of tumour necrosis factor in childhood inflammatory bowel disease. …

Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease

TJ Ślebioda, Z Kmieć - Mediators of inflammation, 2014 - Wiley Online Library
bowel disease (IBD) is a group of inflammatory conditions of the gastrointestinal tract of unclear
aetiology of which two major forms are Crohn’s disease (CD… of the tumour necrosis factor

Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease

L Peyrin-Biroulet, G Van Assche, D Gómez-Ulloa… - Clinical …, 2017 - Elsevier
… Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic inflammatory conditions of the
gut and comprise the main types of inflammatory bowel disease (IBD). The main signs and …

[HTML][HTML] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease

F Hoentjen, AA Van Bodegraven - World journal of …, 2009 - ncbi.nlm.nih.gov
bowel disease (IBD), in particular Crohn’s disease refractory to conventional therapy,
fistulizing Crohn’s disease … respond well to anti-tumor necrosis factor (TNF) therapy. However, …

Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease

M Noguchi, N Hiwatashi, Z Liu, T Toyota - Gut, 1998 - gut.bmj.com
… Several factors have been implicated as possible initiating events in inflammatory bowel
disease (IBD), including enteric bacteria or bacterial cell wall components. These factors may …

Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease

CJM Williams, L Peyrin‐Biroulet… - Alimentary …, 2014 - Wiley Online Library
… One proposed mediator of inflammation in inflammatory bowel disease (IBD) is the pro-inflammatory
cytokine tumour necrosis factor-α (TNFα), concentrations of which are elevated in …

[HTML][HTML] Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

U Billmeier, W Dieterich, MF Neurath… - World journal of …, 2016 - ncbi.nlm.nih.gov
factor, Apoptosis Core tip: To improve the response rates of patients with inflammatory
bowel diseases to anti-tumor necrosis factor (TNF) therapy, it is mandatory to understand the …

[HTML][HTML] Study of tumor necrosis factor receptor in the inflammatory bowel disease

RF Souza, MAF Caetano, HIR Magalhães… - World Journal of …, 2023 - ncbi.nlm.nih.gov
factor-alpha Core Tip: This review summarizes the role of Tumor Necrosis Factor-alpha (TNF…
cytokines involved in the pathogenesis of Inflammatory Bowel Diseases (IBD). In addition, …